Holloman v. Greater Cleveland Regional Transit Authority

741 F. Supp. 677, 5 I.E.R. Cas. (BNA) 896, 1990 U.S. Dist. LEXIS 7639, 1990 WL 83696
CourtDistrict Court, N.D. Ohio
DecidedApril 17, 1990
DocketC88-0774
StatusPublished
Cited by2 cases

This text of 741 F. Supp. 677 (Holloman v. Greater Cleveland Regional Transit Authority) is published on Counsel Stack Legal Research, covering District Court, N.D. Ohio primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Holloman v. Greater Cleveland Regional Transit Authority, 741 F. Supp. 677, 5 I.E.R. Cas. (BNA) 896, 1990 U.S. Dist. LEXIS 7639, 1990 WL 83696 (N.D. Ohio 1990).

Opinion

MEMORANDUM OF OPINION RE: GRANTING DEFENDANT’S MOTION FOR SUMMARY JUDGMENT

KRENZLER, District Judge.

The Plaintiff, Anthony M. Holloman, filed a Complaint with this Court against his former employer, the Greater Cleveland Regional Transit Authority (“GCRTA”) and against his collective bargaining representative, the Amalgamated Transit Union, Local 286 (“Union”) and its president, Ronald iW. Jackson.

In the Complaint plaintiff stated that; (1) GCRTA instituted a drug testing program without the authorization of the members of the Union, thereby breaching the collective bargaining agreement, (2) the Union failed to adequately represent, advise, or assist him, and (3) even if there were sufficient authority for the institution of the drug and alcohol testing program, said program violated the plaintiff's Constitutional rights of privacy and due process, and was unconstitutional because of vagueness.

GCRTA and the Union filed motions to dismiss plaintiff’s first and second claims. 1 As the plaintiff had not exhausted his administrative remedies, this ■ Court found that it was without jurisdiction to determine his allegations against the defendant GCRTA for breach of the collective bargaining agreement and against the Union for failure to fairly represent the plaintiff and dismissed said claims without prejudice.

Presently pending before the Court is Defendant’s Motion For Summary Judgment on plaintiff’s third claim under 42 U.S.C. § 1983, that the GCRTA violated his constitutional right to privacy by requiring him to submit to a series of drug tests following an accident involving a GCRTA bus driven by him and requiring him to submit to drug testing at his bi-annual physical. In support of the motion, defendant has submitted evidentiary material including affidavits of James Clark, the Director of Bus Transportation for the GCRTA, and Neil Fortner, the Scientific Director of Toxicology at Southgate Medical Laboratory, Inc., and a transcript of Plaintiff’s Deposition. The plaintiff filed a brief in response supported by plaintiff’s affidavit.

I.

A review of the pleadings, deposition, affidavits and other evidentiary material reveals the following relevant facts.

The GCRTA is a regional transit authority which provides public transportation services to approximately 240,000 people daily in Northeastern Ohio. The GCRTA operates passenger buses, rapid transit lines, and special community responsive transit vehicles (designed to transport the physically handicapped). On a typical business day, there are over 550 buses in operation.

In February of 1986 the GCRTA implemented a comprehensive “Alcohol and Drug Abuse Policy” (“Drug Policy”) designed to detect (1) employees who use drugs and/or alcohol on the job, and (2) employees who are chronic abusers of drugs and/or alcohol. Plaintiff received, read, and understood the Policy provisions.

The Drug Policy lists a variety of specific circumstances which mandate submission by an employee to toxicological testing for the presence of alcohol and drugs. 2

*679 On December 8, while driving a GCRTA bus on a “swing run,” plaintiff “rear-ended” a passenger automobile. 3 After plaintiff filed an accident report later that day, he was advised by his supervisor, that pursuant to the GCRTA Drug Policy, plaintiff would be required to submit to a drug test. His supervisor transported him to the main testing facility of Southgate Medical Laboratory, Inc. 4

After verifying plaintiffs name and employee number a laboratory technician asked plaintiff to write his name on adhesive labels that were subsequently attached to his test samples. The technician then took two blood samples from plaintiff, and affixed initialed labels to the sample containers before placing them in a refrigerated unit. Plaintiff then provided a saliva sample which was also sealed with an adhesive label.

Plaintiff was next given a specimen jar, directed to a bathroom located off a partitioned area of the lab, and asked to provide a urine sample. No one entered the bathroom with plaintiff nor directly observed plaintiff provide the sample. After providing his sample, plaintiff handed the specimen container to the lab technician who then affixed an initialed adhesive label to the container in plaintiffs presence.

The specimen was subsequently analyzed for the presence of various psychoactive substances. The drug tests revealed a positive showing of marijuana in plaintiffs urine. On December 10, a representative of Southgate Laboratory contacted James Clark, the Assistant Director of Bus Transportation for the GCRTA, and advised him that plaintiffs urine specimen had tested positive for marijuana. That same day plaintiff was informed by District Superintendent Berry Grant that he had tested positive for marijuana. Subsequent to a pre-termination hearing plaintiff was discharged.

During a hearing to appeal his termination, plaintiff acknowledged smoking marijuana the day before the test, but in light of plaintiffs overall work record it was decided to convert plaintiffs discharge to a 30-day suspension, after which he was to be retested. This decision also provided that a second positive marijuana test at the end of this 30-day suspension would result in an additional 30-day suspension. A third positive test at the end of the two suspensions would result in an irrevocable termination. However, if any of those follow-up tests were negative, the GCRTA agreed to conditionally reinstate plaintiff, subject to random testing for three years after reinstatement. Detection of a nonprescription drug at a subsequent testing would result in his immediate discharge. This was reduced to writing and signed by the plaintiff.

Plaintiff served his 30-day suspension and on January 7, submitted to a second urinalysis at a medical facility located at the GCRTA’s downtown headquarters. Plaintiff was directed to the facility’s pri *680 vate' restroom by a physician. The restroom is located'in a room adjacent to and separate from the main examining areas, with its own door. Plaintiff entered the restroom alone. No one entered with him, stood outside the door, or observed him as he provided the sample. Plaintiff then gave the sample to the receptionist and the same “chain of custody” procedures that had been followed on December 8, during plaintiff's first drug test were followed again on January 7.

Once again, plaintiff’s urine tested positive for marijuana and plaintiff was again suspended for an additional 30 days.

On February 8, plaintiff was tested a third time. The place and procedure for this test was identical in all pertinent respects to the previous test- in January. This time, the test results were negative and plaintiff was reinstated to full-time status. As part of the reinstatement process, plaintiff signed a statement in which he agreed to the conditions of his reinstatement, 5

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Bocanegra v. Vicmar Services, Inc.
320 F.3d 581 (Fifth Circuit, 2003)
Kemp v. Claiborne County Hospital
763 F. Supp. 1362 (S.D. Mississippi, 1991)

Cite This Page — Counsel Stack

Bluebook (online)
741 F. Supp. 677, 5 I.E.R. Cas. (BNA) 896, 1990 U.S. Dist. LEXIS 7639, 1990 WL 83696, Counsel Stack Legal Research, https://law.counselstack.com/opinion/holloman-v-greater-cleveland-regional-transit-authority-ohnd-1990.